Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H33N2O2 |
Molecular Weight | 369.5203 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
[H][C@@]12N(C)C3=C(C=CC=C3)[C@]14C[C@H]5[C@@H]([C@H]4O)[C@@]6([H])C[C@]2([H])[N@+]5(CCC)[C@H](O)[C@H]6CC
InChI
InChIKey=UAUHEPXILIZYCU-ALHOSYKFSA-N
InChI=1S/C23H33N2O2/c1-4-10-25-17-11-14(13(5-2)22(25)27)19-18(25)12-23(21(19)26)15-8-6-7-9-16(15)24(3)20(17)23/h6-9,13-14,17-22,26-27H,4-5,10-12H2,1-3H3/q+1/t13-,14-,17-,18-,19-,20-,21+,22+,23+,25-/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Efficacy of prajmaline (Neo-Gilurytmal) objectifiable by means of a test]. | 1983 May 5 |
|
Effects of oral prajmaline bitartrate on exercise test responses in patients with coronary artery disease. | 1985 |
|
Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy. | 1990 Jun |
|
The structure of the ring-opened N beta-propyl-ajmaline (Neo-Gilurytmal) at physiological pH is obviously responsible for its better absorption and bioavailability when compared with ajmaline (Gilurytmal). | 2000 Jul |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C01BA08
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
||
|
WHO-VATC |
QC01BA08
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2230
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
35080-11-6
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
100000078848
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
76959818
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
75934UD4GJ
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
SUB15002MIG
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
m9090
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
8622
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | RxNorm | ||
|
PRAJMALINE
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
D011219
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY | |||
|
DB13555
Created by
admin on Fri Dec 15 16:18:40 GMT 2023 , Edited by admin on Fri Dec 15 16:18:40 GMT 2023
|
PRIMARY |
ACTIVE MOIETY